Appointment to the Human Drug Advisory Panel (HDAP)
The Patented Medicine Prices Review Board (PMPRB) requests your assistance in identifying suitable candidates for appointment to its Human Drug Advisory Panel (HDAP).
We would appreciate receiving your suggestions by April 25, 2022 for names of individuals who would be suitable candidates for the HDAP. 
Click here for details